Prof Dr Tarkan Karakan Gastroenteroloji uzmanı Probiyotik Prebiyotik Derneği Başkanı Mikrobiyota takıntısı olan bilim insanı Ancient Astronauts bağımlısı
You don’t need to reinvent the wheel...
Planning an #IBD project in LMICs?
The ECCO consensus identifies key #research gaps & practical recommendations from authors across the globe— a valuable resource for researchers
Read the open-access article
https://t.co/Q5xcXOj65I
SEQUENCE group which I had the chance to collaborate, published this amazing paper:
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn’s Disease | New England Journal of Medicine https://t.co/GQPmSWqBiI
The impact of the adherence to Mediterranean diet and physical activity on #IBD prognosis
⭐️Healthy lifestyle was associated with:
- Lower risk of mod-severe relapses (aHR, 0.250; 0.093-0.670)
- Steroids use (aHR 0.292; 0.103-0.828)
- Lower risk of mod-severe relapses (aHR 0.270; 0.093-0.789) in UC patients
Congratulations @fgomollon and rest of authors 🤩
https://t.co/DOIVRzAp45
@KrugCleveland@IBD_Houston@novakkerri She will be an excellent president I think, apart from her scientific aspect she also has great communication skills